Eptinezumab Reduced the Frequency of Migraine Days in Patients With Chronic Migraine and Medication-Overuse Headache: Subgroup Analysis of PROMISE-2 H. -C. Diener,M. Marmura,J. Hirman,L. Mehta,T. Brevig,E. Brunner,R. CadyHEADACHE(2020)引用 2|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要